HFmrEF: Clinical Trials

1 trial for HFmrEF, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow HFmrEF: new trials by email Literature Review of HFmrEF trials Research Report on HFmrEF

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)
Combination therapy, Monotherapy - Combined Pre- and Post-capillary Pulmonary Hypertension, CpcPH
Phase 4RecruitingGachon University Gil Medical Center642025-11-242026-04-03

Interventions

Combined Modality Therapy (1)

Sponsors

Gachon University Gil Medical Center (1)

Countries

South Korea (1)